IMMUNE NETWORK

The Korean Association of Immunobiologists (대한면역학회)
권호 표지
DOI QR코드

DOI QR Code

Attenuation of Hepatic Graft-versus-host Disease in Allogeneic Recipients of MyD88-deficient Donor Bone Marrow

  • Lim, Ji-Young (Department of Internal Medicine, Seoul St. Mary's hospital, College of Medicine, The Catholic University of Korea) ;
  • Lee, Young-Kwan (Department of Biomedical Sciences, Seoul National University College of Medicine) ;
  • Lee, Sung-Eun (Department of Internal Medicine, Seoul St. Mary's hospital, College of Medicine, The Catholic University of Korea) ;
  • Ju, Ji-Min (Department of Biomedical Sciences, Seoul National University College of Medicine) ;
  • Park, Gyeongsin (Department of Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Choi, Eun Young (Department of Biomedical Sciences, Seoul National University College of Medicine) ;
  • Min, Chang-Ki (Department of Internal Medicine, Seoul St. Mary's hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2015.02.16
  • Accepted : 2015.05.30
  • Published : 2015.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Acute graft-versus-host-disease (GVHD) is characterized by selective damage to the liver, the skin, and the gastrointestinal tract. Following allogeneic hematopoietic stem cell transplantation, donor bone marrow (BM) cells repopulate the immune system of the recipient. We previously demonstrated that the acute intestinal GVHD (iGVHD) mortality rate was higher in MyD88-deficient BM recipients than that in the control BM recipients. In the present study, the role of MyD88 (expressed by donor BM) in the pathophysiology of hepatic GVHD (hGVHD) was examined. Unlike iGVHD, transplantation with MyD88-deficient T-cell depleted (TCD) BM attenuated hGVHD severity and was associated with low infiltration of T cells into the liver of the recipients. Moreover, GVHD hosts, transplanted with MyD88-deficient TCD BM, exhibited markedly reduced expansion of $CD11b^+Gr-1^+$ myeloidderived suppressor cells (MDSC) in the liver. Adoptive injection of the MDSC from wild type mice, but not MyD88-deficient mice, enhanced hepatic T cell infiltration in the MyD88-deficient TCD BM recipients. Pre-treatment of BM donors with LPS increased MDSC levels in the liver of allogeneic wild type BM recipients. In conclusion, hGVHD and iGVHD may occur through various mechanisms based on the presence of MyD88 in the non-T cell compartment of the allograft.

Keywords

References

  1. Hill, G. R., J. M. Crawford, K. R. Cooke, Y. S. Brinson, L. Pan, and J. L. Ferrara. 1997. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90: 3204-3213.
  2. Caron, G., D. Duluc, I. Fremaux, P. Jeannin, C. David, H. Gascan, and Y. Delneste. 2005. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory $CD4^+$ T cells. J. Immunol. 175: 1551-1557. https://doi.org/10.4049/jimmunol.175.3.1551
  3. Heimesaat, M. M., A. Nogai, S. Bereswill, R. Plickert, A. Fischer, C. Loddenkemper, U. Steinhoff, S. Tchaptchet, E. Thiel, M. A. Freudenberg, U. B. Gobel, and L. Uharek. 2010. MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut 59: 1079-1087. https://doi.org/10.1136/gut.2009.197434
  4. Quigley, M., J. Martinez, X. Huang, and Y. Yang. 2009. A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection. Blood 113: 2256-2264. https://doi.org/10.1182/blood-2008-03-148809
  5. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241. https://doi.org/10.1016/j.cell.2004.07.002
  6. Szabo, G., A. Dolganiuc, and P. Mandrekar. 2006. Pattern recognition receptors: a contemporary view on liver diseases. Hepatology 44: 287-298. https://doi.org/10.1002/hep.21308
  7. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122. https://doi.org/10.1016/S1074-7613(00)80086-2
  8. Min, C. K., Y. Maeda, K. Lowler, C. Liu, S. Clouthier, D. Lofthus, E. Weisiger, J. L. Ferrara, and P. Reddy. 2004. Paradoxical effects of interleukin-18 on the severity of acute graft-versus- host disease mediated by $CD4^+$ and $CD8^+$ T-cell subsets after experimental allogeneic bone marrow transplantation. Blood 104: 3393-3399. https://doi.org/10.1182/blood-2004-02-0763
  9. Comer, G. M., W. G. Ramey, D. P. Kotler, and P. R. Holt. 1986. Isolation of intestinal mononuclear cells from colonoscopic biopsies for immunofluorescence analysis by flow cytometry. Dig. Dis. Sci. 31: 151-156. https://doi.org/10.1007/BF01300700
  10. De, W., V, R. N. Van, M. Hill, J. F. Lebrun, P. Lemaitre, F. Lhomme, C. Kubjak, B. Vokaer, G. Oldenhove, L. M. Charbonnier, M. C. Cuturi, M. Goldman, and M. A. Le. 2009. Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am. J. Transplant. 9: 2034-2047. https://doi.org/10.1111/j.1600-6143.2009.02757.x
  11. Matte, C. C., J. Liu, J. Cormier, B. E. Anderson, I. Athanasiadis, D. Jain, J. McNiff, and W. D. Shlomchik. 2004. Donor APCs are required for maximal GVHD but not for GVL. Nat. Med. 10: 987-992. https://doi.org/10.1038/nm1089
  12. Zarember, K. A., and P. J. Godowski. 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168: 554-561. https://doi.org/10.4049/jimmunol.168.2.554
  13. Hritz, I., A. Velayudham, A. Dolganiuc, K. Kodys, P. Mandrekar, E. Kurt-Jones, and G. Szabo. 2008. Bone marrow-derived immune cells mediate sensitization to liver injury in a myeloid differentiation factor 88-dependent fashion. Hepatology 48: 1342-1347. https://doi.org/10.1002/hep.22557
  14. Shulman, H. M., P. Sharma, D. Amos, L. F. Fenster, and G. B. McDonald. 1988. A coded histologic study of hepatic graft-versushost disease after human bone marrow transplantation. Hepatology 8: 463-470. https://doi.org/10.1002/hep.1840080305
  15. Delano, M. J., P. O. Scumpia, J. S. Weinstein, D. Coco, S. Nagaraj, K. M. Kelly-Scumpia, K. A. O'Malley, J. L. Wynn, S. Antonenko, S. Z. Al-Quran, R. Swan, C. S. Chung, M. A. Atkinson, R. Ramphal, D. I. Gabrilovich, W. H. Reeves, A. Ayala, J. Phillips, D. Laface, P. G. Heyworth, M. Clare-Salzler, and L. L. Moldawer. 2007. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204: 1463-1474. https://doi.org/10.1084/jem.20062602
  16. Wang, D., Y. Yu, K. Haarberg, J. Fu, K. Kaosaard, S. Nagaraj, C. Anasetti, D. Gabrilovich, and X. Z. Yu. 2013. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice. Biol. Blood Marrow Transplant. 19: 692-702. https://doi.org/10.1016/j.bbmt.2013.01.008
  17. Ghansah, T., K. H. Paraiso, S. Highfill, C. Desponts, S. May, J. K. McIntosh, J. W. Wang, J. Ninos, J. Brayer, F. Cheng, E. Sotomayor, and W. G. Kerr. 2004. Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses. J. Immunol. 173: 7324-7330. https://doi.org/10.4049/jimmunol.173.12.7324
  18. Zhou, Z., D. L. French, G. Ma, S. Eisenstein, Y. Chen, C. M. Divino, G. Keller, S. H. Chen, and P. Y. Pan. 2010. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells 28: 620-632.
  19. Highfill, S. L., P. C. Rodriguez, Q. Zhou, C. A. Goetz, B. H. Koehn, R. Veenstra, P. A. Taylor, A. Panoskaltsis-Mortari, J. S. Serody, D. H. Munn, J. Tolar, A. C. Ochoa, and B. R. Blazar. 2010. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 116: 5738-5747. https://doi.org/10.1182/blood-2010-06-287839

Cited by

  1. Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives vol.7, pp.None, 2015, https://doi.org/10.3389/fimmu.2016.00539
  2. Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation vol.11, pp.None, 2015, https://doi.org/10.3389/fimmu.2020.00989